Scoping review of anticancer drug utilization in lung cancer patients at the end of life
This review provides a comprehensive overview of primary studies exploring end-of-life treatments in lung cancer patients. Methodological inconsistencies pose many challenges, revealing a notable proportion of patients experiencing potential overtreatment, warranting more standardized research methods for robust evaluations.
Authors
- Mohammed Merzah (ORCID: https://orcid.org/0000-0003-4019-6290)
- Xavier Bonfill (ORCID: https://orcid.org/0000-0003-1530-3509)
- Iván Solà (ORCID: https://orcid.org/0000-0003-0078-3706)
- Gerard Urrútia (ORCID: https://orcid.org/0000-0002-8850-0960)
- Endre Szigethy (ORCID: https://orcid.org/0000-0002-7812-9600)
Institutions
- Universitat Autònoma de Barcelona (ES)
- University of Debrecen (HU)
- Iberoamerican Cochrane Centre (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Al-Furat Al-Awsat Technical University (IQ)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1007/s12094-024-03711-1
- Citations
- 2
- Primary Topic
- Palliative Care and End-of-Life Issues
- Type
- article
- Field-Weighted Citation Impact
- 1.09
Funders
- Universitat Autònoma de Barcelona